Identifying targets for development of COVID-19 drugs & vaccines
AMSBIO has extended its COVID-19 research portfolio with the introduction of a service to provide custom lentivirus pseudotyped with spike glycoprotein from SARS-CoV-2 to help researchers identify potential targets for development of therapeutic drugs and vaccines.
.png)
No hay comentarios:
Publicar un comentario